Market Value115,221,913
Total Holdings61
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BLUE / bluebird bio, Inc.
QURE / uniQure N.V.
KNSA / Kiniksa Pharmaceuticals, Ltd.
QDEL / QuidelOrtho Corporation
ZNTL / Zentalis Pharmaceuticals, Inc.
PGNY / Progyny, Inc.
FOLD / Amicus Therapeutics, Inc.
OM / Outset Medical, Inc.
SILK / Silk Road Medical, Inc
VTYX / Ventyx Biosciences, Inc.
ETRN / Equitrans Midstream Corporation
CABA / Cabaletta Bio, Inc.
CHRS / Coherus Oncology, Inc.
ALMS / Alumis Inc.
OVV / Ovintiv Inc.
IFRX / InflaRx N.V.
KALV / KalVista Pharmaceuticals, Inc.
TSVT / 2seventy bio, Inc.
SRPT / Sarepta Therapeutics, Inc.
ATEC / Alphatec Holdings, Inc.
GTHX / G1 Therapeutics, Inc.
FHTX / Foghorn Therapeutics Inc.
TVTX / Travere Therapeutics, Inc.
LQDA / Liquidia Corporation
AXGN / Axogen, Inc.
BHVN / Biohaven Ltd.
PRTA / Prothena Corporation plc
BDSX / Biodesix, Inc.
AXSM / Axsome Therapeutics, Inc.
ELUT / Elutia Inc.
SWTX / SpringWorks Therapeutics, Inc.
HALO / Halozyme Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
XENE / Xenon Pharmaceuticals Inc.
PTGX / Protagonist Therapeutics, Inc.
MASI / Masimo Corporation
TXG / 10x Genomics, Inc.
WVE / Wave Life Sciences Ltd.
KROS / Keros Therapeutics, Inc.
PHR / Phreesia, Inc.
CGEM / Cullinan Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
GOSS / Gossamer Bio, Inc.
APLS / Apellis Pharmaceuticals, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
HROW / Harrow, Inc.
BMY / Bristol-Myers Squibb Company
UTHR / United Therapeutics Corporation
CORT / Corcept Therapeutics Incorporated
ARVN / Arvinas, Inc.
XNCR / Xencor, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
XOM / Exxon Mobil Corporation
AXDX / Accelerate Diagnostics, Inc.
NVCR / NovoCure Limited
BPMC / Blueprint Medicines Corporation
DCGO / DocGo Inc.
STOK / Stoke Therapeutics, Inc.
PBAX / Phoenix Biotech Acquisition Corp.
CSTL / Castle Biosciences, Inc.
ALKS / Alkermes plc
TMCI / Treace Medical Concepts, Inc.
INBX / Inhibrx Biosciences, Inc.
EQT / EQT Corporation
KPTI / Karyopharm Therapeutics Inc.